Results 181 to 190 of about 29,488 (242)
Functional combinatorial precision medicine for predicting and optimizing soft tissue sarcoma treatments. [PDF]
NPJ Precis OncolChan SPY, Rashid MBMA, Lim JJ, Goh JJN, Wong WY, Hooi L, Ismail NN, Luo B, Chen BJ, Noor NFBM, Phua BXM, Villanueva A, Sam XX, Ong CJ, Chia CS, Abidin SZ, Yong MH, Kumar K, Ooi LL, Tay TKY, Woo XY, Toh TB, Yang VS, Chow EK. +23 moreeuropepmc +1 more sourceBET degraders reveal BRD4 disruption of 7SK and P-TEFb is critical for effective reactivation of latent HIV in CD4+ T-cells. [PDF]
J VirolTurner A-MW, Bashore FM, Falcinelli SD, Fox JA, Keller AL, Fenton AD, Geyer RF, Allard B, Kirchherr JL, Archin NM, James LI, Margolis DM. +11 moreeuropepmc +1 more sourceNovel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells
, 2017 Dyana T. Saenz, Warren Fiskus, Yimin Qian, Taghi Manshouri, Kimal Rajapakshe, Kanak Raina, Kevin Coleman, Andrew P. Crew, Angela Shen, Christopher P. Mill, Baohua Sun, Ping Qiu, Tapan M. Kadia, Naveen Pemmaraju, Courtney DiNardo, MS Kim, Agnieszka Nowak, Cristian Coarfa, Craig M. Crews, Srđan Verstovšek, Kapil N. Bhalla +20 moreopenalex +1 more sourceBET inhibitors (BETi) influence oxidative phosphorylation metabolism by affecting mitochondrial dynamics leading to alterations in apoptotic pathways in triple-negative breast cancer (TNBC) cells. [PDF]
Cell ProlifRossi T, Iorio E, Chirico M, Pisanu ME, Amodio N, Cantafio MEG, Perrotta I, Colciaghi F, Fiorillo M, Gianferrari A, Puccio N, Neri A, Ciarrocchi A, Pistoni M. +13 moreeuropepmc +1 more sourceEpigenetic Therapies in Endocrine-Related Cancers: Past Insights and Clinical Progress. [PDF]
Cancers (Basel)Varun D, Haque M, Jackson-Oxley J, Thompson R, Kumari AA, Woodcock CL, Harris AE, Madhusudan S, Rakha E, Rutland CS, Mongan NP, Jeyapalan JN. +11 moreeuropepmc +1 more source